Diamyd Medical AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005162880
SEK
9.88
-0.24 (-2.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 1,377 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.83

stock-summary
Return on Equity

-60.45%

stock-summary
Price to Book

4.92

Revenue and Profits:
Net Sales:
(Quarterly Results - May 2025)
Net Profit:
-44 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.28%
0%
-19.28%
6 Months
1.54%
0%
1.54%
1 Year
-32.48%
0%
-32.48%
2 Years
42.82%
0%
42.82%
3 Years
-38.1%
0%
-38.1%
4 Years
-11.67%
0%
-11.67%
5 Years
-67.52%
0%
-67.52%

Diamyd Medical AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.61%
EBIT Growth (5y)
-283.27%
EBIT to Interest (avg)
-73.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.84
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
11.49%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.45
EV to EBIT
-6.95
EV to EBITDA
-7.20
EV to Capital Employed
27.04
EV to Sales
1294.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-389.22%
ROE (Latest)
-60.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended May 2025 is -100.00% vs 0.00% in May 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended May 2025 is -9.48% vs -94.66% in May 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "May'25",
        "May'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-47.50",
          "val2": "-39.90",
          "chgp": "-19.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-43.90",
          "val2": "-40.10",
          "chgp": "-9.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-794,384.60%",
          "chgp": "79,438.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2024 is -80.00% vs 0.00% in Aug 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2024 is -30.75% vs -12.17% in Aug 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Aug'24",
        "Aug'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.50",
          "chgp": "-80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-144.90",
          "val2": "-112.70",
          "chgp": "-28.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-151.80",
          "val2": "-116.10",
          "chgp": "-30.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,198,784.60%",
          "val2": "-215,313.20%",
          "chgp": "-98,347.14%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - YoYstock-summary
May'25
May'24
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-47.50
-39.90
-19.05%
Interest
0.80
0.00
Exceptional Items
-0.50
0.00
Consolidate Net Profit
-43.90
-40.10
-9.48%
Operating Profit Margin (Excl OI)
0.00%
-794,384.60%
79,438.46%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended May 2025 is -100.00% vs 0.00% in May 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended May 2025 is -9.48% vs -94.66% in May 2024

Annual Results Snapshot (Consolidated) - Aug'24stock-summary
Aug'24
Aug'23
Change(%)
Net Sales
0.10
0.50
-80.00%
Operating Profit (PBDIT) excl Other Income
-144.90
-112.70
-28.57%
Interest
0.00
0.00
Exceptional Items
-9.80
0.00
Consolidate Net Profit
-151.80
-116.10
-30.75%
Operating Profit Margin (Excl OI)
-1,198,784.60%
-215,313.20%
-98,347.14%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Aug 2024 is -80.00% vs 0.00% in Aug 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Aug 2024 is -30.75% vs -12.17% in Aug 2023

stock-summaryCompany CV
About Diamyd Medical AB stock-summary
stock-summary
Diamyd Medical AB
Pharmaceuticals & Biotechnology
Diamyd Medical AB is a Sweden-based diabetes company. It is active in the field of pharmaceutical development and investments in stem cell and medical technology. The Company develops the diabetes vaccine, Diamyd, with the active glutamic acid decarboxylase (GAD) ingredient for the treatment and prevention of autoimmune diabetes. The vaccine is intended for the treatment of children and adolescents with recent-onset type one diabetes, as well as those at high risk of developing the disease.
Company Coordinates stock-summary
Company Details
Kungsgatan 29 , STOCKHOLM None : 111 56
stock-summary
Tel: 46 8 6610026
stock-summary
Registrar Details